CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BetterLife Pharma Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BetterLife Pharma Inc
1275 WEST 6TH AVENUE
Phone: (438) 884-8841p:438 884-8841 VANCOUVER, BC  V6H 1A6  Canada Fax: (604) 551-5178f:604 551-5178

Business Summary
BetterLife Pharma Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001 is a non-hallucinogenic Lysergic Acid Diethylamide (LSD) derivative. BETR-001 mimics the projected therapeutic properties of LSD without causing its undesirable side effects such as hallucinations and cardiac toxicity. BETR-001 is a therapy to treat debilitating psychiatric disorders with high unmet need, such as major depressive disorder and anxiety disorders; as well as neurological disorders such as neuropathic pain. BETR-002 is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound for treatment of benzodiazepine dependency, anxiety and spasticity. The Company also owns a drug candidate for the treatment of viral infections such as COVID-19. The Company’s subsidiaries include MedMelior Inc., BetterLife Pharma US Inc. and Blife Therapeutics Inc.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
10/31/20231/31/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director AhmadDoroudian 61 1/1/2021 9/1/2007
Chief Financial Officer Moira W.Ong 47 12/1/2010 12/1/2010
Chief Operating Officer of MedMelior HooshmandSheshbaradaran 65 8/31/2020 8/31/2020
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
IndUS Pharmaceuticals Inc. 25 Olympia Avenue Woburn MA United States

Business Names
Business Name
BETR
ERS Holdings, LLC
IndUS Pharmaceuticals Inc.
8 additional Business Names available in full report.

General Information
Number of Employees: 4 (As of 1/31/2023)
Outstanding Shares: 113,825,305 (As of 10/31/2023)
Shareholders: 46
Stock Exchange: CNQ
Fax Number: (604) 551-5178
Email Address: ir@neurokine.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024